Contact: Jim Dryden
jdryden@wustl.edu
314-286-0110
Washington University School of Medicine
Caption: The most common form of cancer in the eye can be deadly. New treatments have allowed doctors to preserve vision in patients with ocular melanoma, but sometimes the cancer can spread beyond the eye to the liver. When that happens, very few patients survive. Now Washington University ophthalmologists at the Siteman Cancer Center and Barnes-Jewish Hospital in St. Louis have developed a prognostic test that can predict which ocular melanoma patients are at the highest risk for spread of their cancer.
Credit: Washington University BioMed Radio
Usage Restrictions: None
Related news release: Genetic test identifies eye cancer tumors likely to spread